Abstract
Rationale and objective
The aims of this study were to examine the differences between 32 opioid-dependent users treated with a very low dose of methadone or undergoing methadone-free abstinence and 32 controls.
Methods
SPECT analysis using [99mTc] TRODAT-1 to assess striatal dopamine transporter (DAT) availability and [123I] ADAM to assess midbrain serotonin transporter (SERT) availability were performed.
Results
Lower striatal DAT and midbrain SERT availabilities were noted in low-dose methadone users. History of metamphatamine use was associated with the lower striatal DAT. The striatal DAT of methadone-free abstainers was also lower than controls. The midbrain SERT availability tended to be higher in the methadone-free abstainers than the low-dose methadone users. The severity of depressive symptoms was negatively correlated with midbrain SERT availability in the opioid users.
Conclusion
The availability of striatal DAT tended to be, and the availability of midbrain SERT was, lower in the opioid users. History of metamphatamine use may confound the difference in straital DAT between controls and opioid users, as midbrain SERT and depressive symptoms are also associated with opioid use and abstinence.
Similar content being viewed by others
References
Beck AT (1993) Cognitive therapy of substance abuse. Guilford, New York
Cerruti C, Pilotte NS, Uhl G, Kuhar MJ (1994) Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Brain Res Mol Brain Res 22:132–138
Chen PS, Yang YK, Lee YS, Yeh TL, Lee IH, Chiu NT, Chu CL (2005) Correlation between different memory systems and striatal dopamine D-2/D-3 receptor density: a single photon emission computed tomography study. Psychol Med 35:197–204
Childress AR, O'Brien CP (2000) Dopamine receptor partial agonists could address the duality of cocaine craving. Trends Pharmacol Sci 21:6–9
Chu LF, Liang DY, Li X, Sahbaie P, D'Arcy N, Liao G, Peltz G, David Clark J (2009) From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics 19:193–205
Cosgrove KP, Tellez-Jacques K, Pittman B, Petrakis I, Baldwin RM, Tamagnan G, Seibyl J, Kosten T, Staley JK (2010) Dopamine and serotonin transporter availability in chronic heroin users: a [(123)I]beta-CIT SPECT imaging study. Psychiatry Res 184:192–195
Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278
Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, Carboni E (1999) Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci 877:461–485
Gerra G, Garofano L, Castaldini L, Rovetto F, Zaimovic A, Moi G, Bussandri M, Branchi B, Brambilla F, Friso G, Donnini C (2005) Serotonin transporter promoter polymorphism genotype is associated with temperament, personality traits and illegal drugs use among adolescents. J Neural Transm 112:1397–1410
Gerra G, Zaimovic A, Castaldini L, Garofano L, Manfredini M, Somaini L, Leonardi C, Gerra ML, Donnini C (2009) Relevance of perceived childhood neglect, 5-HTT gene variants and hypothalamus–pituitary–adrenal axis dysregulation to substance abuse susceptibility. Am J Med Genet 2010:715–722
Grace AA (2000) The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95(Suppl 2):S119–S128
Guo JF, Yang YK, Chiu NT, Yeh TL, Chen PS, Lee IH, Chu CL (2006) The correlation between striatal dopamine D-2/D-3 receptor availability and verbal intelligence quotient in healthy volunteers. Psychol Med 36:547–554
Hesse S, Barthel H, Murai T, Muller U, Muller D, Seese A, Kluge R, Sabri O (2003) Is correction for age necessary in neuroimaging studies of the central serotonin transporter? Eur J Nucl Med Mol Imaging 30:427–430
Hser YI, Hoffman V, Grella CE, Anglin MD (2001) A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 58:503–508
Hsieh PC, Yeh TL, Lee IH, Huang HC, Chen PS, Yang YK, Chiu NT, Lu RB, Liao MH (2010) Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers. J Psychiatry Neurosci 35:90–94
Huang CI, Yao WJ, Sun YN (2010) New methods for registering long-time I-123 ADAM SPECT image sequences to magnetic resonance images. Nucl Med Commun 31:734–740
Hwang WJ, Yao WJ, Wey SP, Ting G (2004) Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J Nucl Med 45:207–213
Jia SW, Wang W, Liu Y, Wu ZM (2005) Neuroimaging studies of brain corpus striatum changes among heroin-dependent patients treated with herbal medicine, U'finer capsule. Addict Biol 10:293–297
Joensuu M, Tolmunen T, Saarinen PI, Tiihonen J, Kuikka J, Ahola P, Vanninen R, Lehtonen J (2007) Reduced midbrain serotonin transporter availability in drug-naive patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry Res 154:125–131
Jones JD, Hall FS, Uhl GR, Riley AL (2010) Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion. Pharmacol Biochem Behav 94:580–587
Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, Adams V, Furukawa Y, Haycock JW (2001) Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology 24:561–567
Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723
Lee Y, Yang MJ, Lai TJ, Chiu NM, Chau TT (2000) Development of the Taiwanese depression questionnaire. Chang Gung Med J 23:688–694
Lehto S, Tolmunen T, Joensuu M, Saarinen PI, Vanninen R, Ahola P, Tiihonen J, Kuikka J, Lehtonen J (2006) Midbrain binding of [123I]nor-beta-CIT in atypical depression. Prog Neuropsychopharmacol Biol Psychiatry 30:1251–1255
Li JY, Wong CH, Huang EY, Lin YC, Chen YL, Tan PP, Chen JC (2001) Modulations of spinal serotonin activity affect the development of morphine tolerance. Anesth Analg 92:1563–1568
Lin R-C, Huang HS-S (2004) A preliminary study on beliefs about drugs abusing and craving for the heroin abusers. J Criminol (Taiwan) 7:29–66
Magalas Z, De Vry J, Tzschentke TM (2005) The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats. Eur J Pharmacol 528:103–109
Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB (1998) Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry 155:832–834
Mark TL, Woody GE, Juday T, Kleber HD (2001) The economic costs of heroin addiction in the United States. Drug Alcohol Depend 61:195–206
Martinez D, Orlowska D, Narendran R, Slifstein M, Liu F, Kumar D, Broft A, Van Heertum R, Kleber HD (2010) Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers. Biol Psychiatry 67:275–278
Melis M, Spiga S, Diana M (2005) The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol 63:101–154
Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, Mach RH (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9:1050–1056
Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, Alavi A (2005) 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med 46:973–977
Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ (2006) Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 163:52–58
Poling J, Pruzinsky R, Kosten TR, Gonsai K, Sofuoglu M, Gonzalez G, Oliveto A (2007) Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. Am J Addict 16:187–194
Proudnikov D, LaForge KS, Hofflich H, Levenstien M, Gordon D, Barral S, Ott J, Kreek MJ (2006) Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes. Pharmacogenet Genomics 16:25–36
Rothman RB, Blough BE, Baumann MH (2008) Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction. Exp Clin Psychopharmacol 16:458–474
Saxon AJ, Oreskovich MR, Brkanac Z (2005) Genetic determinants of addiction to opioids and cocaine. Harv Rev Psychiatry 13:218–232
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33, quiz 34–57
Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, Deng Y, Shuai Y, Jin J, Lu L (2008) PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 579:160–166
Tao R, Ma Z, Auerbach SB (1998) Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine. J Pharmacol Exp Ther 286:481–488
Tassin JP (2008) Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. Biochem Pharmacol 75:85–97
Tella SR, Ladenheim B, Cadet JL (1997) Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. J Pharmacol Exp Ther 281:508–513
Tjon GH, De Vries TJ, Ronken E, Hogenboom F, Wardeh G, Mulder AH, Schoffelmeer AN (1994) Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation. Eur J Pharmacol 252:205–212
Tzschentke TM, Magalas Z, De Vry J (2006) Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat. Addict Biol 11:64–71
Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J, Dewey SL, Hitzemann R, Lieberman J (1996) Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci USA 93:10388–10392
Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377–382
Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26:6583–6588
Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56(Suppl 1):3–8
Way EL, Loh HH, Shen F (1968) Morphine tolerance, physical dependence, and synthesis of brain 5-hydroxytryptamine. Science 162:1290–1292
Weitemier AZ, Murphy NP (2009) Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversion. Eur J Neurosci 29:1015–1026
Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, Brasic JR, Kimes AS, Maris MA, Kumar A, Contoreggi C, Links J, Ernst M, Rousset O, Zukin S, Grace AA, Lee JS, Rohde C, Jasinski DR, Gjedde A, London ED (2006) Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31:2716–2727
Wu CC, Chen JY, Tao PL, Chen YA, Yeh GC (2005) Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine. Eur J Pharmacol 512:37–42
Wu LT, Woody GE, Yang C, Blazer DG (2010) Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend 112:69–80
Xiao ZW, Cao CY, Wang ZX, Li JX, Liao HY, Zhang XX (2006) Changes of dopamine transporter function in striatum during acute morphine addiction and its abstinence in rhesus monkey. Chin Med J (Engl) 119:1802–1807
Xu K, Lichtermann D, Lipsky RH, Franke P, Liu X, Hu Y, Cao L, Schwab SG, Wildenauer DB, Bau CH, Ferro E, Astor W, Finch T, Terry J, Taubman J, Maier W, Goldman D (2004) Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 61:597–606
Yang YK, Yeh TL, Chiu NT, Lee IH, Chen PS, Lee LC, Jeffries KJ (2004) Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiatry Res 131:209–216
Yang YK, Yao WJ, Yeh TL, Lee IH, Chen KC, Lu RB (2007) Association between serotonin transporter availability and hostility scores in healthy volunteers—a single photon emission computed tomography study with [(123)I] ADAM. Psychiatry Res 154:281–284
Yang YK, Yao WJ, Yeh TL, Lee IH, Chen PS, Lu RB, Chiu NT (2008a) Decreased dopamine transporter availability in male smokers—a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry 32:274–279
Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT, Lu RB (2008b) Greater availability of dopamine transporters in patients with major depression—a dual-isotope SPECT study. Psychiatry Res 162:230–235
Yeh TL, Lee IH, Chen PS, Yu L, Cheng SH, Yao WJ, Yang YK, Lu RB, Chiu NT (2009) Social support and striatal dopaminergic activities: is there a connection? Prog Neuropsychopharmacol Biol Psychiatry 33:1141–1146
Zhao ZQ, Gao YJ, Sun YG, Zhao CS, Gereau RW, Chen ZF (2007) Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward. Proc Natl Acad Sci USA 104:14519–14524
Acknowledgments
This study was supported by grants from the Atomic Energy Council of Taiwan (962014L, 970930L, NL81376 to Y.K.Y.), the National Science Council of Taiwan (NSC 97-NU-7-006-001 to Y.K.Y., NSC 97-2314-B-006-006-MY3 to Y.K.Y., and NSC 98-2314-B-006-024 to C.K.C.), and in part by a Ministry of Health Grant DOH98-TD-I-111-DD004 (R.B.L.), in addition to a grant from the National Cheng Kung University Project of Promoting Academic Excellence & Developing World Class Research Centers, Taiwan, Republic of China (R.B.L.). The authors gratefully acknowledge the administrative support of YH Chang, CJ Wang, HY Lin, HY Chen, CT Lin, and Linda Chang.
Conflict of interest
All authors declare that they have no conflicts of interest. The funding institutions for this study had no further role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeh, T.L., Chen, K.C., Lin, SH. et al. Availability of dopamine and serotonin transporters in opioid-dependent users—a two-isotope SPECT study. Psychopharmacology 220, 55–64 (2012). https://doi.org/10.1007/s00213-011-2454-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-011-2454-6